Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 41.51M | 29.07M | 13.03M | 5.14M | 755.00K |
| Total Other Revenue | 7.71M | 6.97M | 6.61M | 6.99M | 8.44M |
| Total Revenue | 49.22M | 36.04M | 19.64M | 12.13M | 9.19M |
| Cost of Revenue | -- | 737.00K | 737.00K | 737.00K | 737.00K |
| Gross Profit | 49.22M | 35.31M | 18.90M | 11.40M | 8.46M |
| SG&A Expenses | 19.09M | 18.82M | 16.88M | 16.95M | 16.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -849.00K | -192.00K | -5.00K | 153.00K | 299.00K |
| Total Operating Expenses | 108.77M | 114.00M | 107.49M | 106.40M | 105.49M |
| Operating Income | -59.56M | -77.95M | -87.85M | -94.26M | -96.30M |
| Income Before Tax | -36.76M | -84.99M | -79.25M | -83.25M | -116.46M |
| Income Tax Expenses | 0.00 | -508.00K | -343.00K | 108.00K | 370.00K |
| Earnings from Continuing Operations | -36.76 | -84.48 | -78.90 | -83.36 | -116.83 |
| Earnings from Discontinued Operations | -- | 0.00 | 0.00 | 13.08M | 8.39M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | 0.00 | 4.93M | 7.38M |
| Net Income | -36.76M | -84.48M | -78.90M | -65.34M | -101.06M |
| EBIT | -59.56M | -77.95M | -87.85M | -94.26M | -96.30M |
| EBITDA | -48.25M | -67.22M | -77.39M | -84.09M | -86.25M |
| EPS Basic | -0.37 | -1.07 | -1.16 | -1.09 | -1.75 |
| Normalized Basic EPS | -0.22 | -0.56 | -0.69 | -0.75 | -1.09 |
| EPS Diluted | -0.60 | -1.30 | -1.39 | -1.32 | -1.75 |
| Normalized Diluted EPS | -0.23 | -0.57 | -0.70 | -0.77 | -1.09 |
| Average Basic Shares Outstanding | 361.85M | 326.99M | 282.48M | 248.21M | 227.85M |
| Average Diluted Shares Outstanding | 393.13M | 358.27M | 313.76M | 279.50M | 227.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |